Rapid suppression of hematopoiesis by standard or pegylated interferon-α
Open Access
- 1 July 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 123 (1) , 141-151
- https://doi.org/10.1053/gast.2002.34175
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- High serum levels of granulocyte-macrophage colony-stimulating factor in patients with liver cirrhosis and granulocytopeniaClinical and Laboratory Haematology, 2008
- Once-weekly recombinant human erythropoetin (Epoetin alfa) facilitates optimal ribavirin (RBV) dosing in hepatitis C virus (HCV)-infected patients receiving interferon-α-2b (IFN)/RBV combination therapyGastroenterology, 2001
- Effect of pegylated (PEG 40kd) interferon (IFN)α-2a on early virus elimination in patients infected with HCV subtype 1Gastroenterology, 2001
- Letters to the Editor: Rapid onset of hematotoxic effects after interferon alpha in hepatitis CJournal of Hepatology, 2000
- In Vitro Study of Neutrophil Apoptosis in Liver Cirrhosis.Internal Medicine, 1998
- Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?Journal of Hepatology, 1997
- Prothrombin Time in Liver Failure: Time, Ratio, Activity Percentage, or International Normalized RatioHepatology, 1996
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- Risks and Benefits of Interferon-α in the Treatment of HepatitisDrug Safety, 1995
- Thrombocytopenia during interferon alfa therapyJAMA, 1991